Be careful out there.
http://www.medpagetoday.com/MeetingCoverage/ACC/57139?xid=NL_breakingnews_2016-04-05&eun=g424561d0r
Two days after HOPE-3 results were lauded as proof of statins' safety and efficacy, CNN quotes a Tweet from @Eric Topol: "first randomized trial to show risk of cataracts w/statins." MedPage Today asks Deepak Bhatt, Steven Nissen, C. Michael Valentine, and Alfred Bove to put this risk into perspective.
No comments:
Post a Comment